News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2667 Results
Celebrating five years of excellence at VinUniversity
Interim Penn President J. Larry Jameson in a lab examining a piece of equipment.

(Image: Courtesy of VinUniversity)

Celebrating five years of excellence at VinUniversity

Interim Penn President J. Larry Jameson visited VinUni in Hanoi, Vietnam, to commemorate the university’s fifth anniversary and Penn’s seventh year of allyship. He delivered a lecture about how excellent universities advance society.
Beth A. Winkelstein reappointed as deputy provost
Beth Winkelstein

Deputy Provost Beth A. Winkelstein.

(Image: Kevin Monko)

Beth A. Winkelstein reappointed as deputy provost

Winkelstein has taught at Penn for more than twenty years as a leader of interdisciplinary research, and has served as deputy provost since 2020.
The motor driving Penn’s biomedical research
Michael Ostap

Michael Ostap is the interim senior vice dean and chief scientific officer of the Perelman School of Medicine.

(Image: Courtesy of Penn Medicine Magazine)

The motor driving Penn’s biomedical research

For nearly three decades, interim senior vice dean and chief scientific officer of the Perelman School of Medicine Michael Ostap has investigated how molecules such as myosin feel force, in an effort to understand how cellular mutations cause disease.

Meredith Lidard Kleeman for Penn Medicine Magazine

Science behind genetic testing for identifying risk of opioid misuse remains unproven
A scientist with a pipette and a test tube with a computer screen in the background.

Image: iStock/Cavan Images

Science behind genetic testing for identifying risk of opioid misuse remains unproven

A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.

Eric Horvath

Developing a tiny anticancer weapon
A cancer cell breaking up.

Image: iStock/Bahaa_Aladdin

Developing a tiny anticancer weapon

Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.

Meagan Raeke

Penn Center for Innovation celebrates 10 years
Scientists holding a model of something (forthcoming)

(Image: Eric Sucar)

Penn Center for Innovation celebrates 10 years

The University’s nexus for technology transfer supports researchers in their innovative efforts, from CAR T to mRNA advancements that have dramatically reshaped the world.
Helping Korean Americans with end-of-life planning is her passion
Eunice Park-Clinton.

Image: Courtesy of Penn Medicine News

Helping Korean Americans with end-of-life planning is her passion

Eunice Park-Clinton, a nurse case manager in the Hospital of the University of Pennsylvania’s Emergency Department, leads seminars for Korean-speaking families to understand end-of-life care, with funding from a Penn Medicine CARES grant.

From Penn Medicine News

Through Literature of Care course, a curriculum of compassion
Aaron Levy and students gathered around a table filled with images.

Aaron Levy, center left, leads a Literature of Care seminar inside the gallery of Public Trust.

nocred

Through Literature of Care course, a curriculum of compassion

Literature of Care, a course offered every fall in the School of Arts & Sciences, explores medical humanities and the role storytelling plays in patient care.